129 related articles for article (PubMed ID: 6481612)
1. Prediction of blood levels following oral administration of weakly acidic drug particles such as sulfa drugs in rabbits from the in vitro dissolution behavior.
Watari N; Kaneniwa N
J Pharmacobiodyn; 1984 Jun; 7(6):351-65. PubMed ID: 6481612
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
[TBL] [Abstract][Full Text] [Related]
3. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
[TBL] [Abstract][Full Text] [Related]
4. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
5. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
6. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
Kaur N; Narang A; Bansal AK
Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
8. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
[TBL] [Abstract][Full Text] [Related]
9. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions.
Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ
Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152
[TBL] [Abstract][Full Text] [Related]
10. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
[TBL] [Abstract][Full Text] [Related]
11. Analysis and prediction of absorption behavior for theophylline orally administered as powders based on gastrointestinal-transit-absorption (Gita) model.
Kadono K; Yokoe J; Ogawara K; Higaki K; Kimura T
Drug Metab Pharmacokinet; 2002; 17(4):307-15. PubMed ID: 15618682
[TBL] [Abstract][Full Text] [Related]
12. Effect of particle dissolution rate on ocular drug bioavailability.
Hui HW; Robinson JR
J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous in vitro and in vivo evaluation of both trimethoprim and sulfamethoxazole from certain dosage forms.
Meshali M; El-Sabbagh H; Ghanem A; Foda A
Pharmazie; 1983 Jun; 38(6):403-6. PubMed ID: 6604284
[TBL] [Abstract][Full Text] [Related]
14. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
Heigoldt U; Sommer F; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
[TBL] [Abstract][Full Text] [Related]
15. Dissolution of slightly soluble drugs. IV. Effect of particle size of sulfonamides on in vitro dissolution rate and in vivo absorption rate, and their relation to solubility.
Kaneniwa N; Watari N
Chem Pharm Bull (Tokyo); 1978 Mar; 26(3):813-26. PubMed ID: 647854
[No Abstract] [Full Text] [Related]
16. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations.
Corrigan OI
Adv Exp Med Biol; 1997; 423():111-28. PubMed ID: 9269487
[TBL] [Abstract][Full Text] [Related]
17. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
18. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
19. Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.
Malmlöf M; Nowenwik M; Meelich K; Rådberg I; Selg E; Burns J; Mascher H; Gerde P
Eur J Pharm Biopharm; 2019 Jun; 139():213-223. PubMed ID: 30862480
[TBL] [Abstract][Full Text] [Related]
20. Preformulation characterization and in vivo absorption in beagle dogs of JFD, a novel anti-obesity drug for oral delivery.
Fan Y; Yang M; Wang Y; Li Y; Zhou Y; Chen X; Shan L; Wei J; Gao C
Drug Dev Ind Pharm; 2015 May; 41(5):801-11. PubMed ID: 24694186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
